DK1322673T3 - Polysaccharider med antithrombotisk aktivitet, der omfatter mindst en kovalent binding til biotin eller et biotinderivat - Google Patents

Polysaccharider med antithrombotisk aktivitet, der omfatter mindst en kovalent binding til biotin eller et biotinderivat

Info

Publication number
DK1322673T3
DK1322673T3 DK01972171T DK01972171T DK1322673T3 DK 1322673 T3 DK1322673 T3 DK 1322673T3 DK 01972171 T DK01972171 T DK 01972171T DK 01972171 T DK01972171 T DK 01972171T DK 1322673 T3 DK1322673 T3 DK 1322673T3
Authority
DK
Denmark
Prior art keywords
biotin
polysaccharides
covalent bond
antithrombotic activity
derivative
Prior art date
Application number
DK01972171T
Other languages
Danish (da)
English (en)
Inventor
Philippe Duchaussoy
Jean-Marc Herbert
Maurice Petitou
Pierre Savi
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of DK1322673T3 publication Critical patent/DK1322673T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DK01972171T 2000-09-22 2001-09-20 Polysaccharider med antithrombotisk aktivitet, der omfatter mindst en kovalent binding til biotin eller et biotinderivat DK1322673T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0012094A FR2814463B1 (fr) 2000-09-22 2000-09-22 Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine
PCT/FR2001/002918 WO2002024754A1 (fr) 2000-09-22 2001-09-20 Polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine

Publications (1)

Publication Number Publication Date
DK1322673T3 true DK1322673T3 (da) 2008-01-14

Family

ID=8854579

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01972171T DK1322673T3 (da) 2000-09-22 2001-09-20 Polysaccharider med antithrombotisk aktivitet, der omfatter mindst en kovalent binding til biotin eller et biotinderivat

Country Status (40)

Country Link
US (3) US6844329B2 (sr)
EP (1) EP1322673B1 (sr)
JP (2) JP5016778B2 (sr)
KR (2) KR100891388B1 (sr)
CN (1) CN1235914C (sr)
AR (1) AR030774A1 (sr)
AT (1) ATE374215T1 (sr)
AU (2) AU2001291960C1 (sr)
BG (1) BG66191B1 (sr)
BR (1) BR0114007A (sr)
CA (1) CA2418815C (sr)
CY (1) CY1108076T1 (sr)
CZ (1) CZ300856B6 (sr)
DE (1) DE60130669T2 (sr)
DK (1) DK1322673T3 (sr)
EA (1) EA005133B1 (sr)
EC (1) ECSP034514A (sr)
EE (1) EE05202B1 (sr)
ES (1) ES2292625T3 (sr)
FR (1) FR2814463B1 (sr)
GE (1) GEP20053616B (sr)
HK (1) HK1053316A1 (sr)
HR (1) HRP20030219B1 (sr)
HU (2) HUP0303551A3 (sr)
IL (2) IL154848A0 (sr)
IS (1) IS2550B (sr)
ME (2) MEP23608A (sr)
MX (1) MXPA03002483A (sr)
NO (2) NO332905B1 (sr)
NZ (1) NZ524472A (sr)
PE (1) PE20020471A1 (sr)
PL (1) PL206727B1 (sr)
PT (1) PT1322673E (sr)
RS (1) RS50730B (sr)
SI (1) SI1322673T1 (sr)
SK (2) SK287054B6 (sr)
TW (1) TWI308153B (sr)
UA (1) UA79736C2 (sr)
WO (1) WO2002024754A1 (sr)
ZA (1) ZA200301692B (sr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2814463B1 (fr) * 2000-09-22 2002-11-15 Sanofi Synthelabo Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine
FR2874924B1 (fr) * 2004-09-09 2006-12-01 Sanofi Aventis Sa Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique
TWI403334B (zh) * 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
TWI376234B (en) * 2005-02-01 2012-11-11 Msd Oss Bv Conjugates of a polypeptide and an oligosaccharide
NZ567221A (en) * 2005-10-10 2010-06-25 Organon Nv Anticoagulant antithrombotic dual inhibitors comprising a biotin label
CN101312747B (zh) * 2005-10-10 2013-03-20 Msd欧斯股份有限公司 包括生物素标记的抗血栓形成双重抑制剂
CN1317035C (zh) * 2005-10-24 2007-05-23 天津大学 基于酰肼基的微粒表面多重生物功能因子组装方法
EP1886696A1 (en) * 2006-08-03 2008-02-13 Endotis Pharma Conjugates of antithrombin binding oligosaccharide derivatives and therapeutic proteins
FR2912409B1 (fr) * 2007-02-14 2012-08-24 Sanofi Aventis Heparines de bas poids moleculaire comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine leur procede de preparation,leur utilisation
EP2145624A1 (en) 2008-07-18 2010-01-20 Sanofi-Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
EP2233143A1 (en) 2009-03-24 2010-09-29 Sanofi-Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
TW201006479A (en) * 2008-07-18 2010-02-16 Sanofi Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
FR2935386B1 (fr) 2008-08-26 2010-09-10 Sanofi Aventis Nouveaux polysaccharides a activite antithrombotique comprenant une liaion covalente avec une chaine amine
CA2735983A1 (en) * 2008-09-10 2010-03-18 Transpharma Medical Ltd. Transdermal delivery of oligosaccharides
CA2746509C (en) 2008-12-19 2018-11-20 Supernus Pharmaceuticals, Inc. Use of molindone for the treatment of impulsive agression
FR2952935B1 (fr) * 2009-11-20 2011-12-02 Sanofi Aventis Procede de preparation du n-biotinyl-6-aminocaproate de n succinimidyle
JP6109574B2 (ja) 2009-12-18 2017-04-05 カタラン、フランス、バインハイム、ソシエテ、アノニムＣａｔａｌｅｎｔ Ｆｒａｎｃｅ Ｂｅｉｎｈｅｉｍ Ｓａ 合成オリゴサッカリドを含有する医薬経口剤形
CZ302669B6 (cs) * 2010-03-29 2011-08-24 Univerzita Palackého v Olomouci Efektivní zpusob biotinylace aminosloucenin pomocí syntézy na pevné fázi pro potreby afinitní chromatografie
CZ302510B6 (cs) * 2010-03-29 2011-06-22 Univerzita Palackého v Olomouci Efektivní zpusob biotinylace sloucenin s karboxylovou skupinou pomocí syntézy na pevné fázi pro potreby afinitní chromatografie
ES2756711T3 (es) 2010-03-31 2020-04-27 Supernus Pharmaceuticals Inc Formulaciones estabilizadas de compuestos del SNC
WO2012042123A1 (fr) 2010-09-10 2012-04-05 Sanofi Polysaccharides biotinyles a activite antithrombotique et presentant une stabilite metabolique amelioree
FR2964660B1 (fr) * 2010-09-10 2012-09-28 Sanofi Aventis Nouveaux polysaccharides biotinyles a activite antithrombotique et presentant une stabilite metabolique amelioree
EP2484366A1 (en) 2011-02-07 2012-08-08 Sanofi Idrabiotaparinux for the treatment of pulmonary embolism and for the secondary prevention of venous thromboembolic events
EP2721044B1 (en) 2011-06-17 2015-11-18 Carbomimetics Synthetic pentasaccharides having short half-life and high activity
US20140135326A1 (en) * 2012-11-13 2014-05-15 Supernus Pharmaceuticals, Inc. Method of treatment of aggression
WO2015195404A1 (en) 2014-06-20 2015-12-23 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for detection of an analyte by movement of tethered microparticles
WO2016205239A1 (en) 2015-06-15 2016-12-22 The United States Of America, As Represented By The Secretary Department Of Health And Human Services Non-hormonal mammalian sperm decoy contraception based on the n-terminus of the zp2 protein
EP3529205B1 (en) 2016-10-21 2022-06-15 The United States of America, as represented by the Secretary, Department of Health and Human Services Molecular nanotags
CN108976318B (zh) * 2017-06-01 2021-03-30 首都医科大学 单-6-(生物素酰胺基)-6-脱氧-β-环糊精及其制备方法和应用
WO2019133727A1 (en) 2017-12-29 2019-07-04 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Universal influenza virus probe set for enrichment of any influenza virus nucleic acid
BR112022000255A8 (pt) 2019-07-09 2022-03-22 Optimvia Llc Métodos para sintetizar polissacarídeos anticoagulantes
CN114556685B (zh) * 2019-10-17 2024-04-02 株式会社自动网络技术研究所 布线模块
WO2022056078A1 (en) 2020-09-11 2022-03-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Rnase h-assisted detection assay for rna (radar)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3960884A (en) * 1974-04-24 1976-06-01 Sergei Ivanovich Zavyalov Method of preparing racemic biotin
AU563351C (en) * 1982-01-15 2003-06-19 Glaxo Group Limited Synthesis of oligosaccharides
IL102758A (en) * 1991-08-23 1997-03-18 Akzo Nv Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them
US20010023288A1 (en) * 1999-07-07 2001-09-20 Wilbur D. Scott Trifunctional reagent for conjugation to a biomolecule
WO2000002050A1 (en) * 1998-07-07 2000-01-13 Department Of Radiation Oncology, University Of Washington Trifunctional reagent for conjugation to a biomolecule
FR2751334B1 (fr) * 1996-07-19 1998-10-16 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2773804B1 (fr) * 1998-01-19 2000-02-18 Sanofi Sa Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant
FR2773801B1 (fr) * 1998-01-19 2000-05-12 Sanofi Sa Nouveaux pentasaccharides, procedes pour leurs preparations et compositions pharmaceutiques les contenant
GB2335490B (en) * 1998-03-20 2003-05-14 Ortho Clinical Diagnostics An assay surface that permits an analyte releasiing step
JP4575595B2 (ja) 1998-07-31 2010-11-04 生化学工業株式会社 新規グリコサミノグリカン及び該物質を有効成分とする医薬組成物
FR2814463B1 (fr) * 2000-09-22 2002-11-15 Sanofi Synthelabo Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine

Also Published As

Publication number Publication date
US8318696B2 (en) 2012-11-27
KR100891388B1 (ko) 2009-04-02
CZ2003814A3 (cs) 2003-06-18
SK287054B6 (sk) 2009-10-07
SK287218B6 (sk) 2010-03-08
NO332905B1 (no) 2013-01-28
AU2001291960C1 (en) 2009-10-08
PT1322673E (pt) 2007-12-03
ECSP034514A (es) 2003-04-25
EE05202B1 (et) 2009-08-17
ATE374215T1 (de) 2007-10-15
BG107650A (bg) 2003-11-28
EP1322673A1 (fr) 2003-07-02
AU9196001A (en) 2002-04-02
CN1466594A (zh) 2004-01-07
KR20080049139A (ko) 2008-06-03
MXPA03002483A (es) 2004-05-24
FR2814463A1 (fr) 2002-03-29
US20040024197A1 (en) 2004-02-05
CA2418815A1 (en) 2002-03-28
US20110144042A1 (en) 2011-06-16
DE60130669D1 (de) 2007-11-08
PL206727B1 (pl) 2010-09-30
CN1235914C (zh) 2006-01-11
CA2418815C (en) 2011-05-10
US7943595B2 (en) 2011-05-17
ES2292625T3 (es) 2008-03-16
NO20110401L (no) 2003-05-22
GEP20053616B (en) 2005-09-26
JP5016778B2 (ja) 2012-09-05
EA200300237A1 (ru) 2003-08-28
IL154848A (en) 2010-11-30
US6844329B2 (en) 2005-01-18
YU19703A (sh) 2006-05-25
HRP20030219B1 (en) 2011-10-31
AU2001291960B2 (en) 2007-03-01
NZ524472A (en) 2004-10-29
UA79736C2 (uk) 2007-07-25
FR2814463B1 (fr) 2002-11-15
EE200300114A (et) 2005-02-15
ZA200301692B (en) 2004-03-01
PE20020471A1 (es) 2002-06-01
HUP0303551A3 (en) 2004-03-29
BG66191B1 (bg) 2011-12-30
WO2002024754A8 (fr) 2003-07-03
KR20030055269A (ko) 2003-07-02
JP2004509902A (ja) 2004-04-02
DE60130669T2 (de) 2008-07-17
AR030774A1 (es) 2003-09-03
JP2012131809A (ja) 2012-07-12
SI1322673T1 (sl) 2008-02-29
ME00080B (me) 2010-10-10
HRP20030219A2 (en) 2003-06-30
IS2550B (is) 2009-10-15
HU1400034D0 (hu) 2004-03-01
MEP23608A (en) 2010-06-10
NO20031295L (no) 2003-05-22
NO20031295D0 (no) 2003-03-20
SK3562003A3 (en) 2003-11-04
TWI308153B (en) 2009-04-01
CY1108076T1 (el) 2014-02-12
RS50730B (sr) 2010-08-31
BR0114007A (pt) 2003-08-12
WO2002024754A1 (fr) 2002-03-28
CZ300856B6 (cs) 2009-08-26
EA005133B1 (ru) 2004-12-30
EP1322673B1 (fr) 2007-09-26
US20060160768A1 (en) 2006-07-20
HK1053316A1 (en) 2003-10-17
IS6733A (is) 2003-02-28
PL363368A1 (en) 2004-11-15
HUP0303551A2 (hu) 2004-03-01
IL154848A0 (en) 2003-10-31

Similar Documents

Publication Publication Date Title
DK1322673T3 (da) Polysaccharider med antithrombotisk aktivitet, der omfatter mindst en kovalent binding til biotin eller et biotinderivat
AU2001291960A1 (en) Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative
EE200000577A (et) Elektronpääsmete või nendega seotud täiustused
DE60026471D1 (de) Akustischer Blitz zum Erhöhen der Penetration
EE00297U1 (et) Kaubakapp
FI991261A (fi) Trie-rakenteeseen perustuva funktionaalinen muisti
DE60105865D1 (de) Hydraulische Anordnung zur Dämpfung der Trägheitskraft
DE50010639D1 (de) Stromsensor nach dem kompensationsprinzip
ATE262507T1 (de) Substituierte n-phenyl-2-hydroxy-2-methyl-3,3,3- trifluorpropanamid-derivative zur erhöhung der pyruvatdehydrogenaseaktivität
DE50002002D1 (de) Kiefermodell
IT250120Y1 (it) Collegamento a polsino
GB9923724D0 (en) Improvements relating to shelving structures
DE60021924T2 (de) Polysaccharide mit immunostimulierender aktivität
DE50008574D1 (de) Gelenk zum verbinden von drei hebeln
ATA17099A (de) Zusatz zum bügelbrett
DK199900347U3 (da) En brændeovn
NO20001298D0 (no) Forbindelseselement mellom to plateformede konstruksjoner
SE0000392L (sv) Förbindningsstycke
ID30432A (id) Metode untuk membantu menghentikan merokok
IT248648Y1 (it) Elemento da associare alle valvole di sicurezza per verificarne laefficienza.
FI990420A0 (fi) Hirsiliitosrakenne
ITRM990518A0 (it) Perfezionamenti ai girarrosti.
UA2218S (uk) Декоративний елемент з структурою дерева
ITPD20020057A1 (it) Struttura prefabbricata da posizionare a copertura di caminetti.
IT1267635B1 (it) Sospensione anteriore a quadrilatero.